Imnovid

Pomalidomide · Bristol-Myers Squibb Pharma EEIG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imnovid, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: EMA Authorised: Imnovid (previously Pomalidomide Celgene) (Pomalidomide) — Bristol-Myers Squibb Pharma EEIG